Analysis of neoadjuvant therapy effect on 30-day postoperative outcomes in gallbladder cancer
In patients undergoing surgical resection for GBC, those with and without NAT had similar rates of readmission and 30-day mortality, however NAT was associated with an increased risk for transfusion. Despite use of a large national database, this study may be underpowered to adequately assess the effect of NAT on perioperative GBC outcomes and thus warrants further investigation.
Authors
- Stephen Stopenski (ORCID: https://orcid.org/0000-0003-0494-2313)
- Francesca Kimelman
- Nicole Martin (ORCID: https://orcid.org/0000-0001-9186-1313)
- Zeljka Jutric (ORCID: https://orcid.org/0000-0003-1792-4376)
- Areg Grigorian (ORCID: https://orcid.org/0000-0002-0998-796X)
- David K. Imagawa (ORCID: https://orcid.org/0000-0002-5947-5313)
- Ron F Wolf
- Shimul A. Shah (ORCID: https://orcid.org/0000-0003-3406-7310)
- Jeffry T. Nahmias (ORCID: https://orcid.org/0000-0003-0094-571X)
Institutions
- University of California, Irvine Medical Center (US)
- University of Cincinnati (US)
Publication Details
- Journal
- Surgery Open Science
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1016/j.sopen.2024.08.001
- Citations
- 2
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.15
Funders
- University of California, Irvine